HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): A chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system

References

• Akizuki S (1989a) The first autopsy case of HAM. Neuropathology of HAM/TSP in Japan. Proceedings of the First Workshop on Neuropathology of Retrovirus Infections. 1989, Y Iwasaki. Tohuku University School of Medicine, SendaiJapan, 1–6
   Google Scholar
• Akizuki S (1989b) An autopsy case of HAM with prolonged steroid therapy; (1989b). Neuropathology of HAM/TSP in Japan. Proceedings of the First Workshop on Neuropathology of Retrovirus Infections. 1989b, Y Iwasaki. Tohuku Iniversity School of Medicine, SendaiJapan, 25–32
   Google Scholar
• Askonas B A, Taylor P M, Esquivel F. Cytotoxic T cells in influenza virus infection. Ann NY Acad Sci 1988; 532: 230–237
   PubMed Web of Science ®Google Scholar
• Battisto J R, Plate J, Shearer G. Cytotoxic T cells: Biology and Relevance to Disease. Ann NY Acad Sci 1988; 532: 1–489
   Google Scholar
• Ben‐Nun A, Liblau R S, Cohen L, Lehmann D, Tournier‐Lasserve E, Rosenzweig A, Zhang J W, Raus J C, Bach M A. Restricted T‐cell receptor V beta gene usage by myelin basic protein‐specific T‐cell clones in multiple sclerosis: Predominant genes vary in individuals. Proc Natl Acad Sci 1991; 88: 2466–2470
   PubMed Web of Science ®Google Scholar
• Bhigjee A I, Wiley C A, Wachsman W, Amenomori T, Pirie D, Bill P L A, Windsor I. HTLV.‐I associated myelopathy. Clinicopathologic correlation with localization of provirus to the spinal cord. Neurology 1991; 41: 1990–1992
   Google Scholar
• Bourdette D N, Whitham R H, Chou Y K, Morrison W J, Atherton J, Kenny C, Liefeld D, Hashim G A, Offner Vandenbark AA. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides. J Immunol 1994; 152: 2510–2519
   PubMed Web of Science ®Google Scholar
• Bucher B, Poupard J A, Vernat J C, DeFreitas E C. Tropical neuropathies and retroviruses: A review. Rev Infect Dis 1990; 12: 890–899
   PubMedGoogle Scholar
• Ceroni M, Piccardo P, Rodgers‐Johnson P, Mora P, Asher D M, Gadjusek D C, Gibbs C J. Intrathecal synthesis of IgG antibodies to HTLV.‐I supports an etiological role for HTLV.‐I in tropical spastic paraperesis. Ann Neurol 1988; 23: S188–S191, Suppl
   Google Scholar
• Chothia C, Boswell D R. Lesk Am The outline structure of the T cell ab receptor. EMRO J 1988; 7: 3745–3755
   PubMed Web of Science ®Google Scholar
• Chou Y K, Morrison W J, Weinberg A D, Dedrick R, Whitham R, Bourdette D N, Hashim G, Offner H, Vandenbark A A. Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides. J Immunol 1994; 152: 2520–2529
   PubMed Web of Science ®Google Scholar
• Cruickshank J K, Rudge P, Dalgleish A G, Newton M, McLean B N, Barnard R O, Kendall B E, Miller D H. Tropical spastic paraparesis and human T cell lymphotropic virus type I in the United Kingdom. Brain 1989; 112: 1057–1090
   PubMed Web of Science ®Google Scholar
• Daenke S, Nightingale S, Cruickshank J K, Bangham C R M. Sequence variants of human T‐cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T‐cell leukemia do not distinguish neurological from leukemic isolates. J Virol 1990; 64: 1278–1282
   PubMedGoogle Scholar
• Davis M M, Bjorkman P J. T cell antigen receptor genes and T cell recognition. Nature 1988; 344: 395–402
   Google Scholar
• Elovaara I, Koenig S, Brewah A, Jacobson S. High HTLV.‐I specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV.‐I associated neurological disease. J Exp Med 1993; 177: 1567–1573
   Google Scholar
• Furukawa Y, Osame M, Kuboto R, Tara M, Yoshida M. Human T‐cell leukemia virus type‐1 (HTLV‐1) tax is expressed at the same level in infected cells of HTLV‐1 associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T‐cell leukemia cells. Blood 1995; 85: 1865–1870
   PubMed Web of Science ®Google Scholar
• Gessain A, Vernant J C, Maurs L, Barin F, Gout O, Calender A, de The G. Antibodies to human T‐lymphotropic virus I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–410
   PubMed Web of Science ®Google Scholar
• Gessain A, Saal F, Gout O, Daniel M T, Flandrin G, de The G, Peries G, Sigaux F. High human T cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells from French West Indian patients with tropical spastic paraparesis. Int J Can 1989; 43: 327–333
   Google Scholar
• Gessain A, Saal F, Gout O, Daniel M T, Flandrin G, de The G, Peries J, Sigaux F. High human T cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells from French West Indian, Guinese and African patients with tropical spastic paraparesis. Blood 1990; 75: 428–433
   PubMed Web of Science ®Google Scholar
• Gessain A, Gout O. Chronic myelopathy associated with human T‐lymphotropic virus type I (HTLV.‐I). Ann Int Med 1992; 117: 933–946
   PubMed Web of Science ®Google Scholar
• Gessain A. Epidemiology of HTLV.‐I and associated diseases (1996). Human T‐cell Lymphotropic Virus Type I, P Hollsberg, D A Hafler. John Wiley and Sons, New York 1996; 33–64
   Google Scholar
• Godoy A J, Kira J, Hasuo K, Goto I. Characterization of cerebral white matter lesions of HTLV.‐I‐associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen‐vasculitis: a semiquantitative MRI study. ‘Neurol Sci 1995; 133(1–2)102–111
   Google Scholar
• Gout O, Baulac M, Gessain A, Saal F, Peries J, Cabrol C, Foucault‐Fetz C, Laplane D, Sigaux F, de The G. Rapid development of myelopathy after HTLV.‐I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322: 383–388
   PubMed Web of Science ®Google Scholar
• Hara M, Sano J, Watanabe R, Honda M. An autopsy case of HAM with a history of blood transfusions. Neuropathology of HAM/TSP in Japan, Proceedings of the First Workshop on Neuropathology of Retrovirus Infections, Y Iwasaki. Tohuku University School of Medicine, SendaiJapan 1989; 75–92
   Google Scholar
• Hira H, Morita M, Iwaki T, Hatae T, Itoyama Y, Kitamoto T, Akizuki S, Goto I, Watanabe T. Detection of human T lymphotropic virus type I (HTLV.‐I) proviral DNA and analysis of T cell receptor VB CDR3 sequences in spinal cord lesions of HTLV.‐I associated myelopathy/tropical spastic paraparesis. J Exp Med 1994; 180: 831–839
   Google Scholar
• Hollsberg P, Hafler D A. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993; 328: 1173–1182
   PubMed Web of Science ®Google Scholar
• Howell M D, Winters S T, Olee T, Powell H C, Carlos D J, Brostoff S W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989; 246: 668–670
   PubMed Web of Science ®Google Scholar
• Itoyama Y, Minato S, Kira J, Goto I, Sato H, Okochi K, Yamamoto N. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV.‐I associated myelopathy. Neurology 1988; 38: 1302–1307
   PubMed Web of Science ®Google Scholar
• Iwasaki I. Pathology of chronic myelopathy associated with HTLV.‐I infection (HAM/TSP). J Neurol Sci 1990; 96: 103–123
   Google Scholar
• Izumo S, Higuchi I, Ijichi T, Tashiro A, Osame M, Yoshimi K, Motokura F, Okumura A. Neuropathological study in two autopsy cases of HTLV.‐I associated myelopathy (HAM). Neuropathology of HAM/TSP in Japan, Proceedings of the First Workshop on Neuropathology of Retrovirus Infections, Y Iwawaki. Tohuku University School of Medicine, SendaiJapan 1989; 7–17
   Google Scholar
• Jacobson S, Zaninovic V, Mora C, Rodgers‐Johnson P, Sheramata W A, Gibbs C J, Gajdusak C, McFarlin D E. Immunological findings in neurological diseases: Activated lymphocytes in tropical spastic paraparesis. Ann Neurol 1988; 23: 196–200
   PubMedGoogle Scholar
• Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin D E. Immunological studies in tropical spastic paraparesis. Ann Neurol 1990; 27: 149–156
   PubMed Web of Science ®Google Scholar
• Jacobson S, Shida H, McFarlin D E, Fauci A S, Koenig S. Circulating CD8+ cytotoxic lymphocytes specific for HTLV.‐I in patients with HTLV.‐I associated neurological disease. Nature 1990b; 348: 245–248
   PubMed Web of Science ®Google Scholar
• Jacobson S. Immune response to retroviruses in the central nervous system: Role in The Neuropathology of HTLV.‐I Associated Neurologic Disease. Sem Neurosci 1992; 4: 285–290
   Google Scholar
• Jacobson S, McFarlin D, Robinson S, Voskuhl R, Martin R, Brewah A, Newell A J, Koenig S. Demonstration of HTLV.‐I specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV.‐I associated neurologic disease. Ann Neurol 1992b; 32: 651–657
   Google Scholar
• Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G. Predominant recognition of human T cell leukemia virus type I (HTLV.‐I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV.‐I infected cells. Int Immunol 1991; 3: 761–767
   PubMed Web of Science ®Google Scholar
• Kannagi M, Matsushita S, Shida H, Harada S. Cytotoxic T cell response and expression of the target antigen in HTLV.‐I infection. Leukemia 1994; 8(Suppl 1)S54–S59
   PubMedGoogle Scholar
• Kira J, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y. Increased HTLV.‐I proviral DNA in HTLV.‐I associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 1991; 29: 194–201
   PubMed Web of Science ®Google Scholar
• Kira J, Itohama Y, Koyanagi Y, Tateishi J, Kishikawa M, Akizuki S, Kobayashi I, Toki N, Sueishi K, Sato H, Sakaki Y, Yamamoto N, Goto I. Presence of HTLV.‐I proviral DNA in central nervous system of patients with HTLV.‐I associated myelopathy. Ann Neurol 1992; 31: 39–45
   PubMedGoogle Scholar
• Kishikawa M, Kurihara K, Kitai K, Kondo T. An autopsy case of HTLV.‐I associated myelopathy (HAM) caused by blood transfusions for uterine adenocarcinoma. Neuropathology of HAM/TSP in Japan, Proceedings of the First Workshop on Neuropathology of Retrovirus Infections, Y Iwasaki. Tohuku University School of Medicine, SendaiJapan 1989; 18–14
   Google Scholar
• Kitajima I, Osame M, Izumo S, Igata A. Immunological studies of HTLV.‐I associated myelopathy. Autoimmunity 1988; 1: 125–131
   PubMedGoogle Scholar
• Kitze B, Puccioni‐Sohler M, Schaffner J, Rieckmann P, Weber T, Felgenhauer K, Bodemer W. Specificity of intrathecal‐ IgG synthesis for HTLV.‐I cor and envelope proteins in HAM/TSP. Acta Neurol Scand 1995; 92(3)213–217
   Google Scholar
• Kobayashi I, Ota K, Yamamoto K, Murakami H, Maruyama S, Kasazima T, Masuda A. Clinical and pathological observations in HTLV.‐I associated myelopathy. Neuropathology of HAM/TSP in Japan, Proceedings of the First Workshop on Neuropathology of Retrovirus Infections, Y Iwasaki. Tohuku University School of Medicine, SendaiJapan 1989; 33–46
   Google Scholar
• Koenig S, Woods R, Brewah A H, Newell A, Jones G, Boone E. Characterization of major histocompatability complex‐(MHC) class I restricted cytotoxic T cell (CTL) responses to Tax in HTLV.‐I infected patients with neurological disease. J Immunol 1993; 156: 3874–3883
   Google Scholar
• Kotzin B L, Karuturi S, Chou Y K, Lafferty J, Forrester J M, Better M, Nedwin G E, Offner H, Vandenbark A A. Preferential T‐cell receptor b‐chain variable gene use in myelin basic protein‐reactive T‐cell clones from patients with multiple sclerosis. Proc Natl Acad Sci 1991; 88: 161–165
   Google Scholar
• Kramer A, Jacobson S, Reuben J F, Murphy El, Wiktor S Z, Cranston B, Figueroa J P, Hanchard B, McFarlin D, Blattner W A. Spontaneous lymphocyte proliferation is elevated in asymptomatic HTLV.‐I positive Jamaicans. Lancet 1989; 8668: 923–924
   Google Scholar
• Kubota R, Fujiyoshi T, Izumo S, Yashiki S, Maruuyama I, Osame M, Sonoda S. Fluctuation of HTLV.‐I proviral DNA in peripheral blood mononuclear cells of HTLV.‐I associated myelopathy. J Neuroimmunol 1993; 42: 147–154
   Google Scholar
• Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M. HTLV.‐I proviral DNA correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV.‐I associated myelopathy. J Neuroimmunol 1994; 53: 23–29
   PubMed Web of Science ®Google Scholar
• Lehky T J, Fox C H, Koenig S, Levin M C, Flerlage N, Izumo S, Sato E, Raine C S, Osame M, Jacobson S. Detection of human T lymphotropic virus type I (HTLV.‐I) tax RNA in the central nervous system of HTLV.‐I associated myelopathy/tropical spastic paraparesis by in situ hybridization. Ann Neurol 1995; 37: 246–254
   Google Scholar
• Leist T P, Cobbold S P, Waldmann H, Aguet M, Zinkernagel R. Functional analysis of T lymphocytes subsets in antiviral host defense. J Immunol 1987; 138: 2278–2281
   PubMed Web of Science ®Google Scholar
• Levin M C, Fox R J, Lehky T, Walter M, Fox C H, Flerlage N, Bamford R, Jacobson S. Polymerase Chain Reaction/in situ Hybridization Detection of HTLV.‐I tax Proviral DNA in peripheral Blood Lymphocytes of Patients with HTLV.‐I Associated Neurologic Disease. J Virol 1996; 70(2)924–933
   Google Scholar
• Link H, Cruz M, Gessain A, Gout O, de The G, Kam‐Hansen S. Chronic progressive myelopathy associated with HTLV.‐I: Oligoclonal IgG and anti‐HTLV.‐I IgG antibodies in the cerebrospinal fluid and serum. Neurology 1989; 39: 1566–1572
   PubMed Web of Science ®Google Scholar
• Lipka J J, Santiago P, Chan L, Reyes G R, Samuel K P, Blattner W A, Shaw G M, Hanson C V, Sninsky J J, Found S K. Modified Western Blot Assay for Confirmation and Differentiation of Human T Cell Lymphotropic Virus Types I and II. J Inf Dis 1991; 164: 400–403
   Google Scholar
• Lipka J J, Myoshi I, Hadlock K G, Reyes G R, Chow T P, Blattner W A, Shaw G M, Hanson C V, Gallo D, Chan L, Foung S K H. Segregation of Human T Cell Lymphotropic Virus Type I and II Infections by Antibody Reactivity to Unique Viral Epitopes. J Infect Dis 1992; 165: 268–272
   PubMed Web of Science ®Google Scholar
• Madden D R, Garboczi D N, Wiley D C. The antigenic identity of peptide‐MHC complexes: A comparison of the conformations of five viral peptides presented by HLA A2. Cell 1993; 75: 693–708
   PubMed Web of Science ®Google Scholar
• Marrack P, Kappler J. The T cell receptor. Science 1987; 238: 1073–1079
   PubMed Web of Science ®Google Scholar
• Matsuda M, Tsukada N, Miyagi K, Yanagisawa N. Increased levels of soluble vascular cell adhesion molecule‐1 (VCAM‐1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type 1 associated myelopathy. J Neuroimmunol 1995; 59(1–2)35–40
   Google Scholar
• Matsui M, Nagumo F, Tadano J, Kuroda Y. Characterization of humoral and cellular immunity in the central nervous system of HAM/TSP. J Neurol Sci 1995; 130(2)183–189
   Google Scholar
• Mattson D H, McFarlin D E, Mora C, Zaninovic V. Central nervous systems lesions detected by magnetic resonance imaging (MRI) of tropical spastic paraplegia. Lancet 1987; 2: 49
   Google Scholar
• Moore G R W, Traugott U, Scheinberg L C, Raine C S. Tropical spastic paraparesis: A model of virus‐induced cytotoxic T‐cell mediated demyelination?. Ann Neurol 1989; 26: 523–530
   Google Scholar
• Morimoto C, Matsuyama T, Oshige C, Tanaka H, Hercend T, Reinherz E L, Schlossman S F. Functional and phenotypic studies of Japanese adult T cell leukemia cells. J Clin Invest 1985; 75: 836–843
   PubMed Web of Science ®Google Scholar
• Moritoyo T, Reinhart T A, Moritoyo H, Sato E, Isumo S, Osame M, Haase A T. Human T‐lymphotropic virus type I associated myelopathy and tax gene expression in CD4+ lymphocytes. Ann Neurol 1996; 40: 84–90
   PubMedGoogle Scholar
• McFarlin D E, Blattner W A. Non‐Aids retroviral infections in humans. Annu Rev Med 1991; 42: 97–105
   Google Scholar
• Nakagawa M, Izumo S, Ijichi S, Kubota J, Arimura K, Kawabata M, Osame M. HTLV.‐I associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirology 1995; 1(1)50–61
   PubMed Web of Science ®Google Scholar
• Niewiesk S, Daenke S, Parker C E, Taylor G, Weber J, Nightingale S, Bangham C R M. The transactivator gene of human T‐cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol 1994; 68: 6778–6781
   Google Scholar
• Nishimura M, McFarlin D E, Jacobson S. Sequence comparisons of HTLV.‐I from HAM/TSP patients and their asymptomatic spouses. Neurology 1993; 43: 2621–2624
   Google Scholar
• Offner H, Hasim G, Vandenbark A A. T cell receptor therapy triggers autoregulation of experimental allergic encephalomyelitis. Science 1990; 251: 430–432
   Google Scholar
• Ohara Y, Iwasaki Y, Izumo S, Kobayashi I, Yoshioka A. Search for human T‐cell leukemia virus type I (HTLV.‐I) proviral sequences by polymerase chain reaction in the central nervous system of HTLV.‐I associated myelopathy. Arch Virol 1992; 124: 31–43
   PubMedGoogle Scholar
• Osame M, Usuku K, Izumo S, Ijchi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV.‐I associated myelopathy: a new clinical entity. Lancet 1986; 1: 1031–1032
   PubMed Web of Science ®Google Scholar
• Osame M, Izumo S, Igata A, Matsumoto M, Matsumoto T, Sonoda S, Tara M, Shibata Y. Blood transfusion and HTLV.‐I associated myelopathy. Lancet 1986b; 104–105
   Google Scholar
• Osame M, McArthur J C. Neurologic manifestations of infection with human T cell lymphotropic virus type I. Diseases of the Nervous System: Clinical Neurobiology, A K Asbury, G M McKhann, W I McDonald. WB Saunders, New York 1990; 1331–1339
   Google Scholar
• Parker C E, Daenke S, Nightingale S, Bangham C R. Activated HTLV.‐I specific cytotoxic T lymphocytes are found in healthy seropositives as well as patients with tropical spastic paraparesis. Virology 1992a; 88: 628–636
   Google Scholar